Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Akela Pharma Inc. AKLPF

Healthcare Biotechnology
"Akela Pharma Inc is engaged in providing contract services comprised of pharmaceutical formulation research and development, pre-clinical, clinical and commercial drug manufacturing, product development and patent litigation support."


GREY:AKLPF - Post by User

Akela Pharma Inc. > Insider
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Consultor1on Apr 17, 2011 9:23am
390 Views
Post# 18442728

RE: RE: RE: Insider

RE: RE: RE: Insider

As soon as Gregory M. McKee, President & CEO of AKL start's putting out some up dates SP could easily move up to the .30-.50. Gregory can't keep saying it's the economy, or the markets, believe it was all the mergers they did in the pass.

Grumpy this morning

Consultor1

GLTA

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities